Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

Discover how a new predictive tool can forecast the risk of chronic kidney disease in type 2 diabetes patients. Learn about its benefits, limitations, and potential for...
Getting quality sleep is challenging for children with type 1 diabetes, who deal with sleep disturbances like device alarms, low episodes, and more. Here we share sleep-...
Lifestyle changes like diet and exercise are key to the prevention and management of diabetes-related complications like foot disease. Here’s why it’s important to be...
Research shows screening children ages 2-6 best predicts childhood type 1 diabetes. Early screening also leads to more timely treatment, better outcomes, and reduced...
Obesity management options include lifestyle changes, medication, and surgery. Here's what you need to know to make informed decisions about what treatments are optimal...
Discover how cold exposure therapy might boost insulin sensitivity and lower blood sugar in people with diabetes. Scientific evidence is still unfolding.
Uncover phase 2 clinical trial results of CagriSema, a promising diabetes treatment showing improvements in A1C, weight loss, and time in range.
Pfizer propels clinical trials for danuglipron, a novel oral GLP-1 medication for obesity and type 2 diabetes, with promising preliminary results for A1C and weight loss.
Explore the role of artificial intelligence in diabetic retinopathy detection with Eyenuk's innovative technology. Here we also examine the disputed effects of GLP-1s on...
New research reveals a higher dementia risk in early-onset diabetes. Preventing prediabetes progression may be key to mitigating this risk.
At the 17th annual Diabetes Forum at ADA 2023, the diaTribe Foundation and TCOYD moderated an expert panel that discussed access and equity issues, breakthrough...
A lot has happened this year advancing time in range as a primary glucose metric in diabetes care globally. Though we aren’t there yet, a panel shared their thoughts on...
Clinical trial participants taking retatrutide for obesity experienced an average of 24% in body weight reduction over 48 weeks. Lead scientists shared their findings at...
PIONEER PLUS and OASIS 1 trials show high-dose Rybelsus significantly reduces A1C and promotes weight loss in type 2 diabetes and obesity patients.
Clinical trial results have shown that once-weekly basal insulins are just as effective at reducing A1C as once-daily insulin.
Results from a recent clinical trial showed the new medication survodutide may be a useful treatment tool for weight loss. People with overweight or obesity on the...
On the search for a type 1 diabetes cure, scientists are experimenting with how to engineer beta cells to survive immune system attacks. At the American Diabetes...
People with type 1 and 2 diabetes report experiencing diabetes stigma regardless of which devices they use. But when we start looking at which groups report the most...
end Uncover SURMOUNT-2 trial's outcomes: Tirzepatide's promise for weight loss, better blood sugar, and improved cardiometabolic health in type 2 diabetes.
New drug treatments are now available for children with diabetes following the recent approval of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin...

Pages